Translating Clinical Data into Nephrology Practice in the Management of Hyperphosphatemia

Translating Clinical Data into Nephrology Practice in the Management of Hyperphosphatemia
1.5 AMA PRA Category 1 Credit(s)
Launch Date:
January 29, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:


Relevant Terms:

Hyperphosphatemia, kidney function, calcium balance, phosphate binders, serum phosphorus, bone and mineral metabolism

Tom Nickolas, MD, MS

Tom Nickolas, MD, MS
Associate Professor of Clinical Medicine
Columbia University Medical Center
Department of Medicine
New York, NY

Tom Nickolas, MD, MS
Associate Professor of Clinical Medicine
Columbia University Medical Center
Department of Medicine
New York, NY
1. Delineate evidence surrounding the pathophysiology of CKD-MBD and the associations between calcium balance and vascular health
2. Compare and contrast previous and emerging calcium and phosphorus balance study data and their impact on clinical practice in patients with CKD-MBD
3. Distinguish the risks, benefits, and optimal application of different classes of phosphate binding agents in the management of patients with CKD-MBD in clinical practice

The American Academy of CME, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

American Academy of CME, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. 
Tom Nickolas, MD, MS reports the following disclosures:
Advisory Board (for scientific information): Merck, Celgene
Intellectual Property/Patents: Columbia University has licensed patents for the use of NGAL as a marker of acute kidney injury.
There will be no discussion of off-label or non-approved products within this activity.
This activity is supported by an educational grant from sanofi-aventis U.S.
Paul J. Miniter, MS, Beth Paczolt, MD, Edward J. Moylan, RPh, and John JD Juchniewicz, MCIS, CHCP, American Academy of CME: No relevant financial relationships with commercial interests.
This activity is designed for use by health care professionals for educational purposes only. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
There are no fees to participate in the enduring activity. 
During the period January 29, 2016 through January 29, 2017, learners must 1) read the CME information, including learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, submit it and your post-test will automatically be graded. Once you successfully complete the post-test (score of 70% or higher) and activity evaluation, your Statement of Credit will be made available immediately to view or print for your records.
For more information about the American Academy of CME privacy policy, please access
For any questions, please contact:
© 2016. This CME-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner.
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above